|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
1 study |
0.07% |
|
|
Communicable diseases |
1 study |
0.07% |
|
|
Disaster risk reduction and health emergencies |
1 study |
0.07% |
|
|
Violence |
1 study |
0.07% |
|
|
|
0 studies |
0.00% |
|
|
"OMIC" technologies |
2 studies |
0.13% |
|
|
Access to essential medical products, vaccines and technologies |
1 study |
0.07% |
|
|
Biomedical products and engineering |
8 studies |
0.53% |
|
|
Communicable diseases |
4 studies |
0.27% |
|
|
Diagnostics |
43 studies |
2.85% |
|
|
Drug discovery and development |
37 studies |
2.46% |
|
|
Emerging and re-emerging diseases |
1 study |
0.07% |
|
|
Filipino traditional and complementary medicine |
1 study |
0.07% |
|
|
Functional foods |
2 studies |
0.13% |
|
|
Genomics/Molecular Technology |
1 study |
0.07% |
|
|
Health information systems |
1 study |
0.07% |
|
|
Information and communication technologies for health |
6 studies |
0.40% |
|
|
Information and communication technology (ICT) for health |
1 study |
0.07% |
|
Global competitiveness and innovation in health |
Oral health |
1 study |
0.07% |
|
|
Accidents and injuries |
1 study |
0.07% |
|
|
Disaster risk reduction and health emergencies |
4 studies |
0.27% |
|
|
Emerging and re-emerging diseases |
6 studies |
0.40% |
|
|
Environmental threats to health |
1 study |
0.07% |
|
|
Health service delivery |
1 study |
0.07% |